The first patient has been dosed in a newly launched global clinical trial evaluating the safety and effectiveness of telitacicept, given as subcutaneous, or under-the-skin, injections, in adults with primary Sjögren’s disease. The Phase 3 study, dubbed UPSTREAM SjD (NCT07404865), will test the therapy, in an estimated 250…
Sjögren’s Awareness Month is marked each year in April, and for this year, advocates and organizations are encouraging people affected by Sjögren’s disease to continue spreading awareness by sharing their personal stories and participating in events across the U.S. Leading the charge is the Sjögren’s Foundation, a Virginia-based nonprofit.
Trinity Biotech, which specializes in diagnostic test kits, is partnering with the University at Buffalo, New York (UB) to develop and commercialize new testing strategies to improve the detection of Sjögren’s disease and aid in its diagnosis. “Sjögren’s is a significantly underdiagnosed condition that imposes a major burden…
People with primary Sjögren’s disease, particularly those with more severe illness, show significantly different patterns of alternative splicing — a process in which cells mix and match gene instructions to create different versions of a protein — in 10 genes compared with healthy people, according to a study in China.
Get regular updates to your inbox.
